Nath Bio-Genes shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health51/100
Valuation
100/100 · PB 0.5076
Technical
Avoid
1M -3.17%
6M 2.779%
1Y -11.275%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present